Surgical Innovations Group PLC
LSE:SUN
Intrinsic Value
Surgical Innovations Group Plc is a holding company, which engages in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and industrial markets. [ Read More ]
The intrinsic value of one
SUN
stock under the Base Case scenario is
1.04
GBX.
Compared to the current market price of 0.5 GBX,
Surgical Innovations Group PLC
is
Undervalued by 52%.
Surgical Innovations Group PLC's market capitalization is 4.7m GBX.
SUN stock price is 0.5 GBX.
SUN stock price (0.5 GBX) is 52% less than its Intrinsic Value (1.04 GBX).
SUN has upside potential of 410% compared to the average analyst price target.
Open Wall St Estimates
SUN's Revenue has grown by 6% over the past 12 months.
SUN has negative Net Debt. This means that the company has more cash and short-term investments (1m GBP) than debt (1m GBP).
SUN's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -4%.
SUN's ROE (Return on Equity) for the past 12 months is negative and is equal to -5%.
SUN has negative Free Cash Flow for the last twelve months.
SUN has positive Gross Profit for the last twelve months.
SUN's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -20% to -4%, and is approaching profitability.
SUN's Revenue has been growing by an exceptional 24% per year for the last 3 years.
SUN's ROE (Return on Equity) has significantly increased in the last 3 years from -28% to -5%, and is approaching profitability.
SUN has negative Operating Income for the last twelve months.
SUN has negative Net Income for the last twelve months.
SUN's short-term assets (6m GBP) exceed its short-term liabilties (3m GBP).
SUN has negative three-year average ROIC (Return on Invested Capital): -5%. The company is not efficient at using invested capital to generate operating income.
SUN has negative three-year average ROE (Return on Equity): -7%. The company is not efficient at transforming stockholders' equity into net income.
SUN's Altman Z-Score is very low and is equal to 1.24.
SUN's D/E (Debt to Equity) is very low and is equal to 0.1.
SUN's long-term assets (14m GBP) exceed its long-term liabilties (4m GBP).
SUN doesn't generate enough operating income (-596k GBP) to safely cover interest payments on its debt (79k GBP).
Valuation Backtest
Surgical Innovations Group PLC
Run backtest to discover the historical profit from buying and selling
SUN
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Surgical Innovations Group PLC
Balance Sheet Decomposition
Surgical Innovations Group PLC
| Current Assets | 6.1m |
| Cash & Short-Term Investments | 1.2m |
| Receivables | 2m |
| Other Current Assets | 2.9m |
| Non-Current Assets | 8.2m |
| PP&E | 1.7m |
| Intangibles | 6.5m |
| Current Liabilities | 2.6m |
| Accounts Payable | 1.6m |
| Accrued Liabilities | 377k |
| Other Current Liabilities | 611k |
| Non-Current Liabilities | 1.2m |
| Long-Term Debt | 1.1m |
| Other Non-Current Liabilities | 165k |
Earnings Waterfall
Surgical Innovations Group PLC
|
Revenue
|
12m
GBP
|
|
Cost of Revenue
|
-8.6m
GBP
|
|
Gross Profit
|
3.4m
GBP
|
|
Operating Expenses
|
-4m
GBP
|
|
Operating Income
|
-596k
GBP
|
|
Other Expenses
|
87k
GBP
|
|
Net Income
|
-509k
GBP
|
Free Cash Flow Analysis
Surgical Innovations Group PLC
SUN Profitability Score
Profitability Due Diligence
Surgical Innovations Group PLC's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Score
Surgical Innovations Group PLC's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
SUN Solvency Score
Solvency Due Diligence
Surgical Innovations Group PLC's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Surgical Innovations Group PLC's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SUN Price Targets Summary
Surgical Innovations Group PLC
According to Wall Street analysts, the average 1-year price target for
SUN
is 2.55 GBX
with a low forecast of 2.53 GBX and a high forecast of 2.63 GBX.
Shareholder Return
SUN Price
Surgical Innovations Group PLC
| Average Annual Return | -12.94% |
| Standard Deviation of Annual Returns | 33.89% |
| Max Drawdown | -90% |
| Market Capitalization | 4.7m GBX |
| Shares Outstanding | 932 816 177 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Surgical Innovations Group PLC
Country
Industry
Market Cap
Dividend Yield
Description
Surgical Innovations Group Plc is a holding company, which engages in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and industrial markets. The Group sells branded products through its Elemental Healthcare Ltd. (Distribution) and independent healthcare distributors across the world and own label products through original equipment manufacturer (OEM) relationships. The firm operates through three segments: SI Brand, OEM and Distribution. The SI Brand segment is engaged in the research, development, manufacture and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. Its Distribution segment is engaged in the distribution of specialist medical products sold through its Elemental Healthcare Ltd.
Contact
IPO
Employees
Officers
The intrinsic value of one
SUN
stock under the Base Case scenario is
1.04
GBX.
Compared to the current market price of 0.5 GBX,
Surgical Innovations Group PLC
is
Undervalued by 52%.
You don't have any saved screeners yet
